NO994757L - Fremgangsmåte for oral administrasjon av proteiner - Google Patents

Fremgangsmåte for oral administrasjon av proteiner

Info

Publication number
NO994757L
NO994757L NO994757A NO994757A NO994757L NO 994757 L NO994757 L NO 994757L NO 994757 A NO994757 A NO 994757A NO 994757 A NO994757 A NO 994757A NO 994757 L NO994757 L NO 994757L
Authority
NO
Norway
Prior art keywords
proteins
oral administration
oral
administration
Prior art date
Application number
NO994757A
Other languages
English (en)
Other versions
NO994757D0 (no
Inventor
Nicholas A Peppas
Anthony M Lowman
Tsuneji Nagai
Mariko Morishita
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of NO994757D0 publication Critical patent/NO994757D0/no
Publication of NO994757L publication Critical patent/NO994757L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO994757A 1997-04-02 1999-09-30 Fremgangsmåte for oral administrasjon av proteiner NO994757L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US6136797P 1997-10-08 1997-10-08
PCT/US1998/006563 WO1998043615A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Publications (2)

Publication Number Publication Date
NO994757D0 NO994757D0 (no) 1999-09-30
NO994757L true NO994757L (no) 1999-11-29

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994757A NO994757L (no) 1997-04-02 1999-09-30 Fremgangsmåte for oral administrasjon av proteiner

Country Status (14)

Country Link
EP (1) EP0975328A1 (no)
JP (1) JP2002512607A (no)
KR (1) KR20010005952A (no)
CN (1) CN1259045A (no)
AU (1) AU727053B2 (no)
BR (1) BR9808466A (no)
CA (1) CA2285457A1 (no)
IL (1) IL132176A0 (no)
NO (1) NO994757L (no)
NZ (1) NZ500075A (no)
PL (1) PL335974A1 (no)
TR (1) TR199903240T2 (no)
WO (1) WO1998043615A1 (no)
YU (1) YU49699A (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (de) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
GB0206048D0 (en) * 2002-03-14 2002-04-24 Croda Int Plc Use
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
US8110212B2 (en) 2005-04-07 2012-02-07 Drexel University Bioactive thermogelling polymer systems and methods of their use
CA2617051C (en) 2005-07-29 2013-12-17 Stichting Groningen Centre For Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
WO2007016600A2 (en) * 2005-08-01 2007-02-08 Mannkind Corporation Method of preserving the function of insulin-producing cells
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (no) 2006-02-22 2015-07-10 Mannkind Corp
JP2010500917A (ja) 2006-06-15 2010-01-14 マイクロベンション, インコーポレイテッド 膨張性ポリマーで構成される塞栓形成デバイス
AU2008345590B2 (en) 2007-12-21 2014-10-30 Microvention, Inc. Hydrogel filaments for biomedical uses
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
BRPI1014645B1 (pt) 2009-04-30 2020-07-07 Technip France método e sistema para compartilhar linhas de amarração
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
JP2013505791A (ja) 2009-09-24 2013-02-21 マイクロベンション インコーポレイテッド 医学的使用のための注射用ヒドロゲル繊維
CN102791183B (zh) 2009-10-26 2015-07-08 微排放器公司 由可膨胀的聚合物构成的栓塞装置
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
EP3137124B1 (en) 2014-04-29 2019-01-09 Microvention, Inc. Polymers including active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
EP4633678A1 (en) * 2022-12-16 2025-10-22 Wake Forest University Health Sciences Hydrogel compositions and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
DE1617393C2 (de) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (fr) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie Matiere seche hydratable en un gel aqueux contenant des particules de polymeres dispersees, procede pour sa preparation et son application en biologie

Also Published As

Publication number Publication date
TR199903240T2 (xx) 2000-05-22
NO994757D0 (no) 1999-09-30
PL335974A1 (en) 2000-06-05
AU6880998A (en) 1998-10-22
JP2002512607A (ja) 2002-04-23
CN1259045A (zh) 2000-07-05
NZ500075A (en) 2001-03-30
KR20010005952A (ko) 2001-01-15
CA2285457A1 (en) 1998-10-08
WO1998043615A1 (en) 1998-10-08
BR9808466A (pt) 2001-08-07
IL132176A0 (en) 2001-03-19
YU49699A (sh) 2002-12-10
AU727053B2 (en) 2000-11-30
EP0975328A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
IS5245A (is) Lyfjablanda úr ómeprasól
NO995134D0 (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
NO986202L (no) FremgangsmÕte for fremstilling av rekombinant adÚnovirus
DE69615887D1 (de) Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
FI973733L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
NO951630L (no) Fremgangsmåte for administrering av azithromycin
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
ZA969001B (en) Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FI963679L (fi) Stabiloitu koostumus peptidien antamiseksi suun kautta
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
KR970000228A (ko) S-에토돌락의 경구용 제제
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO986177L (no) FremgangsmÕte for fremstilling av terapeutisk DNA
EE04154B1 (et) Omeprasooli valmistamise meetod
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
FI973229L (fi) Uusi farmaseuttinen koostumus
FI974578L (fi) Menetelmä levosimendaanin antamiseksi
NO994049D0 (no) Metode for å fremstille farmasöytiske forbindelser
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI974235A0 (fi) Ny bestaemningsmetod
KR970000226A (ko) S-이부프로펜의 경구용 제형
KR970701559A (ko) 펩타이드의 경구 투여를 위한 안정화된 조성물(stabilized composition for oral administration of peptides)
UA25519A (uk) Спосіб іhтракаротидhого введеhhя лікарських препаратів
NO994977D0 (no) Fremstilling av enantiomerfrie biarylketokarboksylsyrer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application